Group One Trading’s Citius Pharmaceuticals CTXR Stock Holding History

Group One Trading’s Portfolio CTXR Stock Details CTXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8	Closed	-$100	–	7393
2024 Q3	$100	Buy	+8	New	+$135	﹤0.01%	6476
2024 Q1	–	Sell	-148	Closed	-$2.8K	–	7182
2023 Q4	$2.8K	Buy	148 +36	+32%	+$683	﹤0.01%	6720
2023 Q3	$1.92K	Sell	112 -16	-13%	-$380	﹤0.01%	7054
2023 Q2	$3.84K	Sell	128 -48	-27%	-$1.58K	﹤0.01%	6831
2023 Q1	$5.15K	Buy	176 +148	+529%	+$4.27K	﹤0.01%	6268
2022 Q4	$553	Hold	28	–	–	﹤0.01%	6932
2022 Q3	$1K	Buy	+28	New	+$770	﹤0.01%	7283

Other funds holding CTXR

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

AAG

Asset Advisory Group Kinnelon, New Jersey $229M AUM

Group One Trading's CTXR Position: Q2 2026 in Review

Group One Trading opened a new position in Citius Pharmaceuticals (CTXR) in Q2 2026: 1,551 shares worth $938. The stake represents ﹤0.01% of the portfolio and ranks #7194 among its holdings. This is a return to the name: Group One Trading previously reported a position in CTXR as recently as Q2 2025.

Group One Trading first reported a position in CTXR in Q3 2022 and has held it in 12 quarters since. The position peaked at $57.2K in Q1 2023. 42 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

Group One Trading held 1,551 shares of Citius Pharmaceuticals worth $938 as of Q2 2026.
Citius Pharmaceuticals was a new Group One Trading position in Q2 2026.
Citius Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7194 holding.
Group One Trading first reported a position in Citius Pharmaceuticals in Q3 2022 and has held it in 12 quarters since.
Group One Trading's Citius Pharmaceuticals position peaked at $57.2K in Q1 2023.
42 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.